All in this together: The corporate capture of public health

BMJ (Online)

Volumn 345, Issue 7888, 2012, Pages

  Mindell, Jennifer S ^a   Reynolds, Lucy ^b   Cohen, David L ^c   McKee, Martin ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COOPERATION; DRUG INDUSTRY; FOOD INDUSTRY; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; INTERPERSONAL COMMUNICATION; LAW; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; SOCIETY; UNITED KINGDOM;

ETHICS, INSTITUTIONAL; GREAT BRITAIN; HEALTH POLICY; HUMANS; LOBBYING; ORGANIZATIONAL OBJECTIVES; POLICY MAKING; PRIVATE SECTOR; PRIVATIZATION; PUBLIC HEALTH ADMINISTRATION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; SOCIAL RESPONSIBILITY;

EID: 84872078395     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e8082     Document Type: Review

References (44)

1. Hastings G. Why corporate power is a public health priority. BMJ 2012;345:e5124.
2. Letwin O. Privatising the world: a study of international privatisation in theory and practice. Cassell Educational, 1988.
3. Care Quality Commission. CQC publishes report on out of hours GP services in Cornwall. 2012. www.cqc.org.uk/media/cqc-publishes-report-out-hours-gp- services-cornwall.
4. Jenkin GL, Signal L, Thomson G. Framing obesity: the framing contest between industry and public health at the New Zealand inquiry into obesity. Obes Rev 2011;12:1022-30.
5. Landman A, Ling PM, Glantz SA. Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control. Am J Public Health 2002;92:917-30.
6. Mindell J. Lessons from tobacco control for advocates of healthy transport. J Public Health Med 2001;23(2):91-7.
7. Daube M. Voluntary agreements: designed to fail. Tob Control 1993;2:183-4.
8. Royal College of Physicians. Smoking and health. Royal College of Physicians, 1962.
9. Sims M, Maxwell R, Bauld L, Gilmore A. Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ 2010;340:c2161.
10. O'Connor RJ, Giovino GA, Fix BV, Hyland A, Hammond D, Fong GT, et al. Smokers' reactions to reduced ignition propensity cigarettes. Tob Control 2006;15:45-9.
11. Eckel RH, Borra S, Lichtenstein AH, Yin-Piazza SY. Understanding the complexity of trans fatty acid reduction in the American diet. American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. Circulation 2007;115:2231-46.
12. Stender S, Dyerberg J, Bysted A, Leth T, Astrup A. A trans world journey. Atheroscler Suppl 2006;7(2):47-52.
13. Dwyer Hogg C. Dying for a burger? Why are trans fats still legal in the UK? Independent 10 September 2011. www.independent.co.uk/life-style/food-and- drink/features/dying-for-a- burger-why-are-trans-fats-still-legal-in-the-uk- 2351306.html
14. Quinn C, Lewis S, Edwards R, McNeill A. Economic evaluation of the removal of tobacco promotional displays in Ireland. Tob Control 2011;20:151-5.
15. Scollo M, Lal A, Hyland A, Glantz S. Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tob Control 2003;12:13-20.
16. Leatherhead Food International. Evaluating the impact on business of changes to nutrition labelling requirements in the UK. Project undertaken for the Food Standards Agency. FSA, 2006.
17. Douglas MJ, Watkins SJ, Gorman DR, Higgins M. Are cars the new tobacco? J Public Health (Oxf) 2011;33:160-9.
18. Bosanquet N, Haldenby A, Hurley L, Jolly F, Rainbow H, Sikora K. Making the NHS the best insurance policy in the world. REFORM, 2008.
19. Cassidy J. Lobby watch: Reform. BMJ 2011;342:d2917.
20. Rogers W, Zutlevics T, Raven M, Jureidini J. Guidance offers little in the way of ethics or transparency. BMJ 2012;344:e2910.
21. Diethelm P, McKee M. Denialism: what is it and how should scientists respond? Eur J Public Health 2009;19:2-4.
22. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289:454-65.
23. Vartanian LR, Schwartz MB, Brownell KD. Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health 2007;97:667-75.
24. Gruning T, Gilmore AB, McKee M. Tobacco industry influence on science and scientists in Germany. Am J Public Health 2006;96:20-32.
25. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998;279:1566-70.
26. Drope J, Bialous SA, Glantz SA. Tobacco industry efforts to present ventilation as an alternative to smoke-free environments in North America. Tob Control 2004;13(suppl 1):i41-7.
27. McKee S. What should you spend on advertising? Bloomberg Business Week 2009. www. businessweek.com/smallbiz/content/feb2009/sb20090210-165498.htm.
28. Brownell KD, Koplan JP. Front-of-package nutrition labeling - an abuse of trust by the food industry? N Engl J Med 2011;364:2373-5.
29. Leys C, Player S. The plot against the NHS. Merlin Press, 2011.
30. Smith KE, Fooks G, Collin J, Weishaar H, Mandal S, Gilmore AB. "Working the system" - British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents. PLoS Med 2010;7(1):e1000202.
31. Love J. Pharma company registered expenditures for USA. http://keionline.org/node/1321. Knowledge Economy International, 2011.
32. Health Action International. Europe/Corporate Europe Observatory. Divide and conquer: a look behind the scenes of the European Union (EU) pharmaceutical industry lobby. 2012. http://corporateeurope.org/sites/default/files/ 28%20March%202012%20DivideConquer.pdf.
33. Regulatory Affairs Associates. FDA corruption and the specter of regulatory capture. Regulatory Affairs Associates www.regaffairs.net/news/fda- corruption-the-specter-of-regulatory- capture.html.2009.
34. Goldacre B. Bad pharma. Fourth Estate, 2012.
35. Kahn J. China quick to execute drug official. New York Times 11 July 2007. www.nytimes. com/2007/07/11/business/worldbusiness/11execute.html?-r= 1&pagewanted=all.
36. Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med 2012;9(6):e1001235.
37. Rose D. The firm that hijacked the NHS. Mail on Sunday 12 February 2012:8-9. www. dailymail.co.uk/news/article-2099940/NHS-health-reforms-Extent- McKinsey-Companys-role- Andrew-Lansleys-proposals.html.
38. Jarman H, Greer SL. In the eye of the storm: civil servants and managers in the UK Department of Health. Soc Pol Admin 2009;44:172-92.
39. Boffey D. NHS reforms: American consultancy McKinsey in conflict-of-interest row. Observer 5 November 2011. www.guardian.co.uk/society/ 2011/nov/05/nhs-reforms-mckinsey- conflict-interest.
40. Department of Health. Invitation to tender for unsustainable providers regime (ITT number: 58529). Acceptance letter to McKinsey & Co. dated 11th July 2012. http://library. constantcontact.com/download/get/file/1102665899193- 1113/SLHT+admin+Award+Letter+to+McKinsey+-+Redacted+Version.pdf.
41. MacFarlane J. NHS wastes £7million on 'sham' consultation over A&E closures . . . as we reveal six more casualty units to be cut. Daily Mail 28 October 2012. www.dailymail. co.uk/news/article-2224150/NHS-wastes- 7million-sham-consultation-A-E-closures-reveal- SIX-casualty-units-cut. html#ixzz2DL56lt85.
42. World Health Organization. Trade, foreign policy, diplomacy and health. Public-private partnerships for health. 2012. www.who.int/trade/glossary/ story077/en/index.html.
43. Lang T, Rayner G. Ecological public health: the 21st century's big idea? An essay by Tim Lang and Geof Rayner. BMJ 2012;345:e5466.
44. House of Commons Public Administration Committee. Third report. Business appointment rules. UK Parliament, 2012. www.publications.parliament.uk/pa/ cm201213/cmselect/cmpubadm/404/40402.htm.